Jiangsu Chengkang Pharmaceutical

Jiangsu Chengkang Pharmaceutical, a subsidiary of Shanghai Acebright Pharmaceuticals Group, is a modern pharmaceutical company and CDMO based in Yancheng, Jiangsu. Founded in 2007, the company specializes in the development and manufacture of anti-tumor, anti-viral, and cardiovascular drugs. It operates GMP-compliant facilities for freeze-dried powder injections and oral solid preparations, offering comprehensive CDMO services from formulation screening to commercial production. Its product portfolio includes approved oncology therapeutics such as bortezomib and pemetrexed, as well as antiretroviral medications for HIV treatment. The company is committed to providing high-quality, affordable medicines and integrated manufacturing solutions for global partners.